RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. North Carolina Biotechnology Center
N

North Carolina Biotechnology Center portfolio

North Carolina Biotechnology Center has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $19M.
Latest deal: Locus Biosciences · Nov 1, 2017.
About this page

Its most recent investment on record is Locus Biosciences's $19M Series A round in November 2017, alongside Starlight Ventures, ARTIS Ventures, Abstract Ventures and 1 other. By category, its portfolio leans toward Health and bio (2).

What North Carolina Biotechnology Center invests in

How North Carolina Biotechnology Center invests

StageDealsCapital in rounds
Series A 1 100%$19M

North Carolina Biotechnology Center portfolio companies

CompanyRound with North Carolina Biotechnology CenterTotal raisedLatest raise
LLocus Biosciences
Health and bio
Series A · $19M$54MFeb 16, 2024
Series B+
BBelhaven Biopharma
Health and bio
backer$21MAug 19, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name North Carolina Biotechnology Center. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists North Carolina Biotechnology Center, which is a subset of its real portfolio. API: /api/v1/investors/north-carolina-biotechnology-center (get a free API key). More: the most active VC firms and new venture capital funds.